Medicap Pharmacy

    Franchise research report · reviewed 2025 disclosure data

    Reviewed sources

    Medicap Pharmacy franchise operates independent community pharmacies that provide personalized prescription services and healthcare products to local neighborho

    Headline figures

    Medicap Pharmacy quick facts

    Is Medicap Pharmacy a franchise?
    Yes. Medicap Pharmacy offers franchises through a Franchise Disclosure Document. At the end of 2025, it reported 59 franchised and 0 company-owned outlets (2025 FDD, Item 20, PDF p. 48).
    How much does it cost to open a Medicap Pharmacy franchise?
    The Medicap Pharmacy Franchise Disclosure Document reports separate estimated initial investments by format: $513,050–$546,653 for new store total initial investment: $513,050–$895,653 (2025 FDD, Item 7, PDF p. 25); $130,000–$546,653 for conversion only (conversion total initial investment: $130,000–$546,653) (2025 FDD, Item 7, PDF p. 25). These formats are not combined. Each is the franchisor's disclosed estimate, not a quote. Details
    What is the Medicap Pharmacy initial franchise fee?
    The disclosed initial franchise fee for a standard single unit is $0 (2025 FDD, Item 5, PDF p. 18). Other fee options (for example multi-unit or conversion) are listed separately in the report. Details
    What ongoing fees does Medicap Pharmacy charge?
    The disclosed ongoing royalty is 3% (2025 FDD, Item 6, PDF p. 19). The brand or advertising fund contribution is $100 (2025 FDD, Item 6, PDF p. 21). Other recurring fees are listed in Item 6. Details
    Does Medicap Pharmacy disclose financial performance (Item 19)?
    No. The reviewed Medicap Pharmacy FDD states that it does not make a financial performance representation in Item 19. Details
    How many Medicap Pharmacy locations are there?
    The FDD reports 59 outlets at the end of 2025 (2025 FDD, Item 20, PDF p. 48). Existing locations do not indicate territory availability. Details
    Is Medicap Pharmacy a good franchise to buy?
    Franopolis does not rate or recommend franchises. From the reviewed FDD: Item 19 makes no financial performance representation, so ask current owners about results; Item 20 lists outlet openings, closures and transfers; Item 6 includes a brand or advertising fund contribution on top of royalty; Item 20 also lists current and former franchisees you can contact. Review the full FDD with a franchise attorney and accountant before deciding.

    From reviewed FDD figures only. Not a recommendation or projection.

    What the disclosures show

    1. 1The 2025 FDD (Item 7) estimates opening costs separately by format: $513,050 – $546,653 (New Store total initial investment: $513,050–$895,653); $130,000 – $546,653 (Conversion total initial investment: $130,000–$546,653); several initial fee options apply.
    2. 2The franchisor makes no financial performance representation in Item 19.
    3. 3Outlets declined by 4 in 2025, to 59 (systemwide, as labeled in the FDD, Item 20).

    From reviewed FDD figures only. Not a recommendation or projection.

    Medicap Pharmacy head-to-head

    Closest peers in the same subcategory, side by side from reviewed FDD figures. Not a ranking or recommendation.

    Costs · Items 5–7

    What does it cost to open?

    Estimated opening costs and the fees payable to the franchisor.

    Startup Investment — Item 7

    Range across 2 single-unit formats

    2025 FDD · Item 7

    Formats disclosed in Item 7 (2)

    Each format has its own total. The total depends on the format you choose.

    • Conversion total initial investment: $130,000–$546,653PDF p. 25$130,000 – $546,653
    • New Store total initial investment: $513,050–$895,653PDF p. 25$513,050 – $546,653

    Standard single-unit franchise fee

    2025 FDD · Item 5 · PDF p. 18
    Discounted and multi-unit options are separate; see all fees.

    Ongoing Fees — Item 6

    Selected recurring charges; payment bases and conditions remain attached to each fee.

    Continuing License Fee: 3% of gross sales or $599/monthMain ongoing fee

    25 reported fees, each with its payment basis, are listed below; they haven't been sorted into recurring, initial and occasional groups yet.

    Financial Performance — Item 19

    What results are disclosed—and for which locations?

    No financial performance representation in Item 19

    The reviewed 2025 FDD for Medicap Pharmacy has no Item 19 figures on record. Franopolis does not estimate revenue or earnings in their place; ask the franchisor and current owners what unit-level information they can share.

    Outlet Changes — Item 20

    How has the outlet count changed?

    systemwide, as labeled in the FDD · counts as of 2025 of each year.

    2025 FDD · Item 20 · PDF p. 48

    Net −8 outlets, 2023–2025

    0672023632024592025−4−4

    Year-end counts reported in Item 20. The scale starts at zero; the labels between the dots show each year's change. Openings and closures for 2025 haven't been pulled from the Item 20 tables yet, so no turnover or churn is shown.

    Questions to investigate

    Prompts based on what this brand's reviewed disclosures do and don't show — not conclusions. Join free as a member to save questions to your research.

    For the franchisor

    • Which line items in the 2025 Item 7 estimate ($130,000 – $546,653) vary most by market, and why?

    • Which initial fee option would apply to my situation, and what conditions or discounts affect it?

    • Medicap Pharmacy reports no financial performance figures in Item 19. What information can you share about unit-level results?

    • Reported units decreased from 63 to 59 in 2025. What drove the change?

    • Is a territory available in my area, and how is it defined in my agreement?

    For current and former owners

    • How did your actual startup costs and timeline compare with the Item 7 estimate?

    • How many hours a week do you work in the business, and in what role?

    • What support from the franchisor has been most and least useful?

    For your advisors

    • Ask a franchise attorney to review the territory, renewal, transfer and termination terms.

    • Ask an accountant to build a cash-flow plan using your own assumptions, not the franchisor's.

    Sources & vintage history

    Every displayed fact is retained with its disclosure vintage, item, page, and reviewed status. Prior vintages remain on file rather than being overwritten.

    Citations (2025 FDD)

    1. [1]Standard initial franchise fee — Item 5 · PDF p. 18
    2. [2]Outlet counts — Item 20, Table 1 · PDF p. 48

    "PDF p." is the page in the PDF file; "printed p." is the number printed on the FDD page.

    Territory & operations

    These are contract disclosures, not confirmation that any territory is currently available.

    Franchisor financial statements

    No verified franchisor financial statement figures have been reviewed yet.

    SBA-backed loans to franchisees

    Loading…

    Source: U.S. Small Business Administration 7(a) & 504 FOIA data. Loan volume is not a measure of franchisee success.

    At a glance

    Business history

    Not reviewed

    Owner participation

    Not reviewed

    Territory language

    Litigation disclosure

    Not reviewed

    Bankruptcy disclosure

    Not reviewed

    Agreement term

    Not reviewed

    Independent analysis of franchisor-provided data. Not investment advice. Franopolis does not distribute FDDs.

    Compare Medicap Pharmacy with…

    VS